atropine: be contraindicated in heart transplant patients

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents drug
Weight: 0.66
, alkaloid
Weight: 0.59
, agent
Weight: 0.57
, substance
Weight: 0.55
, medicine
Weight: 0.51
Siblings phenobarbital
Weight: 0.36
, acetaminophen
Weight: 0.36
, ibuprofen
Weight: 0.35
, morphine
Weight: 0.35
, metronidazole
Weight: 0.35

Related properties

Property Similarity
be contraindicated in heart transplant patients 1.00
be contraindicated in heart block 0.89
be contraindicated in myasthenia gravis 0.88
be contraindicated in hypertrophy 0.86
be contraindicated in prostatic hypertrophy 0.85
be contraindicated in hypothermia 0.83
be ineffective in patients with transplanted hearts 0.83
be ineffective in patients with hearts 0.78
be used for bradycardia 0.77
be given for bradycardia 0.77

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Salient implies Plausible

0.26
Rule weight: 0.28
Evidence weight: 0.92
Similarity weight: 1.00
Evidence: 0.91
Plausible(atropine, be contraindicated in heart transplant patients) ⋁
Evidence: 0.94
¬ Salient(atropine, be contraindicated in heart transplant patients)

Similarity expansion

0.74
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.89
Evidence: 0.97
Typical(atropine, be contraindicated in heart transplant patients) ⋁
Evidence: 0.92
¬ Typical(atropine, be contraindicated in heart block)
0.73
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.88
Evidence: 0.97
Typical(atropine, be contraindicated in heart transplant patients) ⋁
Evidence: 0.91
¬ Typical(atropine, be contraindicated in myasthenia gravis)
0.72
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.86
Evidence: 0.97
Typical(atropine, be contraindicated in heart transplant patients) ⋁
Evidence: 0.72
¬ Typical(atropine, be contraindicated in hypertrophy)
0.71
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.89
Evidence: 0.94
Salient(atropine, be contraindicated in heart transplant patients) ⋁
Evidence: 0.90
¬ Salient(atropine, be contraindicated in heart block)
0.71
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.85
Evidence: 0.97
Typical(atropine, be contraindicated in heart transplant patients) ⋁
Evidence: 0.59
¬ Typical(atropine, be contraindicated in prostatic hypertrophy)
0.71
Rule weight: 0.85
Evidence weight: 0.95
Similarity weight: 0.88
Evidence: 0.94
Salient(atropine, be contraindicated in heart transplant patients) ⋁
Evidence: 0.85
¬ Salient(atropine, be contraindicated in myasthenia gravis)
0.70
Rule weight: 0.85
Evidence weight: 0.92
Similarity weight: 0.89
Evidence: 0.91
Plausible(atropine, be contraindicated in heart transplant patients) ⋁
Evidence: 0.86
¬ Plausible(atropine, be contraindicated in heart block)
0.70
Rule weight: 0.85
Evidence weight: 0.95
Similarity weight: 0.86
Evidence: 0.94
Salient(atropine, be contraindicated in heart transplant patients) ⋁
Evidence: 0.83
¬ Salient(atropine, be contraindicated in hypertrophy)
0.70
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.83
Evidence: 0.97
Typical(atropine, be contraindicated in heart transplant patients) ⋁
Evidence: 0.85
¬ Typical(atropine, be contraindicated in hypothermia)
0.69
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.88
Evidence: 0.91
Plausible(atropine, be contraindicated in heart transplant patients) ⋁
Evidence: 0.83
¬ Plausible(atropine, be contraindicated in myasthenia gravis)
0.69
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.83
Evidence: 0.97
Typical(atropine, be contraindicated in heart transplant patients) ⋁
Evidence: 0.91
¬ Typical(atropine, be ineffective in patients with transplanted hearts)
0.69
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.86
Evidence: 0.91
Plausible(atropine, be contraindicated in heart transplant patients) ⋁
Evidence: 0.72
¬ Plausible(atropine, be contraindicated in hypertrophy)
0.69
Rule weight: 0.85
Evidence weight: 0.95
Similarity weight: 0.85
Evidence: 0.94
Salient(atropine, be contraindicated in heart transplant patients) ⋁
Evidence: 0.79
¬ Salient(atropine, be contraindicated in prostatic hypertrophy)
0.68
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.85
Evidence: 0.91
Plausible(atropine, be contraindicated in heart transplant patients) ⋁
Evidence: 0.63
¬ Plausible(atropine, be contraindicated in prostatic hypertrophy)
0.68
Rule weight: 0.85
Evidence weight: 0.95
Similarity weight: 0.83
Evidence: 0.94
Salient(atropine, be contraindicated in heart transplant patients) ⋁
Evidence: 0.74
¬ Salient(atropine, be contraindicated in hypothermia)
0.67
Rule weight: 0.85
Evidence weight: 0.95
Similarity weight: 0.83
Evidence: 0.94
Salient(atropine, be contraindicated in heart transplant patients) ⋁
Evidence: 0.82
¬ Salient(atropine, be ineffective in patients with transplanted hearts)
0.66
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.83
Evidence: 0.91
Plausible(atropine, be contraindicated in heart transplant patients) ⋁
Evidence: 0.74
¬ Plausible(atropine, be contraindicated in hypothermia)
0.66
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.83
Evidence: 0.91
Plausible(atropine, be contraindicated in heart transplant patients) ⋁
Evidence: 0.82
¬ Plausible(atropine, be ineffective in patients with transplanted hearts)
0.65
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.78
Evidence: 0.97
Typical(atropine, be contraindicated in heart transplant patients) ⋁
Evidence: 0.71
¬ Typical(atropine, be ineffective in patients with hearts)
0.65
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.77
Evidence: 0.97
Typical(atropine, be contraindicated in heart transplant patients) ⋁
Evidence: 0.59
¬ Typical(atropine, be used for bradycardia)
0.65
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.77
Evidence: 0.97
Typical(atropine, be contraindicated in heart transplant patients) ⋁
Evidence: 0.65
¬ Typical(atropine, be given for bradycardia)
0.65
Rule weight: 0.85
Evidence weight: 0.97
Similarity weight: 0.78
Evidence: 0.94
Salient(atropine, be contraindicated in heart transplant patients) ⋁
Evidence: 0.41
¬ Salient(atropine, be ineffective in patients with hearts)
0.65
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.77
Evidence: 0.94
Salient(atropine, be contraindicated in heart transplant patients) ⋁
Evidence: 0.31
¬ Salient(atropine, be given for bradycardia)
0.64
Rule weight: 0.85
Evidence weight: 0.97
Similarity weight: 0.77
Evidence: 0.94
Salient(atropine, be contraindicated in heart transplant patients) ⋁
Evidence: 0.40
¬ Salient(atropine, be used for bradycardia)
0.63
Rule weight: 0.85
Evidence weight: 0.96
Similarity weight: 0.77
Evidence: 0.91
Plausible(atropine, be contraindicated in heart transplant patients) ⋁
Evidence: 0.43
¬ Plausible(atropine, be given for bradycardia)
0.63
Rule weight: 0.85
Evidence weight: 0.96
Similarity weight: 0.77
Evidence: 0.91
Plausible(atropine, be contraindicated in heart transplant patients) ⋁
Evidence: 0.47
¬ Plausible(atropine, be used for bradycardia)
0.63
Rule weight: 0.85
Evidence weight: 0.95
Similarity weight: 0.78
Evidence: 0.91
Plausible(atropine, be contraindicated in heart transplant patients) ⋁
Evidence: 0.53
¬ Plausible(atropine, be ineffective in patients with hearts)
0.58
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.77
Evidence: 0.47
Remarkable(atropine, be contraindicated in heart transplant patients) ⋁
Evidence: 0.24
¬ Remarkable(atropine, be given for bradycardia)
0.56
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.78
Evidence: 0.47
Remarkable(atropine, be contraindicated in heart transplant patients) ⋁
Evidence: 0.30
¬ Remarkable(atropine, be ineffective in patients with hearts)
0.56
Rule weight: 0.85
Evidence weight: 0.74
Similarity weight: 0.88
Evidence: 0.47
Remarkable(atropine, be contraindicated in heart transplant patients) ⋁
Evidence: 0.49
¬ Remarkable(atropine, be contraindicated in myasthenia gravis)
0.55
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.83
Evidence: 0.47
Remarkable(atropine, be contraindicated in heart transplant patients) ⋁
Evidence: 0.43
¬ Remarkable(atropine, be contraindicated in hypothermia)
0.55
Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.83
Evidence: 0.47
Remarkable(atropine, be contraindicated in heart transplant patients) ⋁
Evidence: 0.43
¬ Remarkable(atropine, be ineffective in patients with transplanted hearts)
0.54
Rule weight: 0.85
Evidence weight: 0.72
Similarity weight: 0.89
Evidence: 0.47
Remarkable(atropine, be contraindicated in heart transplant patients) ⋁
Evidence: 0.54
¬ Remarkable(atropine, be contraindicated in heart block)
0.53
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.77
Evidence: 0.47
Remarkable(atropine, be contraindicated in heart transplant patients) ⋁
Evidence: 0.38
¬ Remarkable(atropine, be used for bradycardia)
0.46
Rule weight: 0.85
Evidence weight: 0.62
Similarity weight: 0.86
Evidence: 0.47
Remarkable(atropine, be contraindicated in heart transplant patients) ⋁
Evidence: 0.72
¬ Remarkable(atropine, be contraindicated in hypertrophy)
0.43
Rule weight: 0.85
Evidence weight: 0.59
Similarity weight: 0.85
Evidence: 0.47
Remarkable(atropine, be contraindicated in heart transplant patients) ⋁
Evidence: 0.78
¬ Remarkable(atropine, be contraindicated in prostatic hypertrophy)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.97
Similarity weight: 1.00
Evidence: 0.94
Salient(atropine, be contraindicated in heart transplant patients) ⋁
Evidence: 0.97
¬ Typical(atropine, be contraindicated in heart transplant patients) ⋁
Evidence: 0.47
¬ Remarkable(atropine, be contraindicated in heart transplant patients)

Typical implies Plausible

0.44
Rule weight: 0.48
Evidence weight: 0.91
Similarity weight: 1.00
Evidence: 0.91
Plausible(atropine, be contraindicated in heart transplant patients) ⋁
Evidence: 0.97
¬ Typical(atropine, be contraindicated in heart transplant patients)